Red White & Bloom Receives Full Licensing, Commences Operation of 15,000 Sq. Ft. Michigan Cannabis Manufacturing/Processing Facility
January 18, 2022
CBD Global Sciences is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns three product categories, branded under the names Aethics, Cannaoil, and Strasburg Pharms Certified. They specialize in a wide range of CBD products, and set new standards of both quality and productivity. Their mission is to provide pure and natural products to the modern consumer, while increasing production and providing deep shareholder value.
February 18, 2021
Denver, Colorado, Feb. 18, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”), is pleased to share that it has created a new distribution company called Legacy Distribution Group.
Legacy Distribution Group, “Legacy Distribution” (Denver, CO) is one of the country’s first CBD-only Direct Store Delivery (DSD) distributors. Until now, CBD brands have had to rely heavily on distributors that may be as new to CBD as the customers they service. While many of these distributors have a long track record of success, their lack of CBD expertise and broader, mostly traditional brand portfolios routinely result in the underperformance of the CBD brands they represent. This is the problem Legacy aims to solve. By providing best-in-class service and unmatched CBD expertise, Legacy’s curated approach is designed specifically to help maximize the growth and market penetration of new and existing CBD brands. Currently, Legacy has begun vetting a new round of CBD brands to be included in their growing portfolio.
CBD Global has enlisted a team of highly skilled distribution and sales managers that have honed their expertise in large scale DSD over the past several decades. The assembly of this team is a collaborative effort with people and companies that have successfully managed and navigated the creation and growth of distribution channel services and we are pleased to launch this project. The team at Legacy Distribution collectively has nearly three decades of experience in DSD operations and nearly a decade long track record of sales success in the CBD space. This unique combination results in an unparalleled ability to successfully open and effectively service new accounts on behalf of the brands in their portfolio. Legacy Distribution has acquired distribution and sales routes that consist of approximately 1,000 points of distribution in the Colorado and surrounding region. These routes were established with CBD infused product in early 2019 and continue to grow with seven major brands being represented.
Brad Wyatt, CEO of CBD Global Sciences, shared, “Direct store delivery is a big piece of my corporate background, running large scale distribution facilities for companies like Target Corporation, Sears Roebuck and Federal Mogul. I’ve found that to be successful in this space leadership needs to surround themselves with solid operators that possess incredible relationships. In the coming months we will be able to share more information about the team, the growing list of distribution agreements with multiple large-scale brands and the likes. We are extremely excited to bring this to the CBD industry with the intent to provide a quicker, more efficient and more affordable path to sales for the CBD Brands that are trying to get their products on the shelf.”
For further information, please contact Bruce Nurse, Investor Relations, (888) 401-2239, firstname.lastname@example.org
In January, CBD Global launched the new product line “Dog Unleashed CBD” in partnership with Dog the Bounty Hunter. Duane “Dog” Chapman has starred in many reality tv shows about his bounty hunting experiences and personal life. Dog currently has a spin-off entitled Dog’s Most Wanted in production at WGN America and his next project, Dog’s Unleashed, is set to premiere in 2021 on the streaming site Unleashed.
His past shows have set viewership records on A&E, WGN and CMT, but Dog’s Unleashed is expected to surpass even those. Dog will be doing many interviews on prominent talk shows about both his series and Dog Unleashed CBD.
Dog struggled for years to find a way to ease the physical and mental pain that came with his job as a bounty hunter. He was always wary of over-the-counter or prescription painkillers, so he was thrilled when he found CBD.
Eventually he decided to create his own brand, but he wanted to work with a company that he knew he could count on to always deliver quality. He chose to partner with CBD Global because they completely control the product with stringent chain of custody requirements. They organically grow hemp and use a cold fusion process to extract the cannabinoids, leading to a full spectrum and pure CBD product. Dog has stated that
Dog Unleashed CBD consists of a robust line of CBD products, aimed at addressing many bodily pains with a natural approach. The product launch will coincide with the release of Dog’s new show, streaming on the Unleashed internet platform.
The initial product line will offer 12 different SKUs in three different strengths 1000MG, 2000MG and 3500MG– all of which are infused with a lab tested, full spectrum CBD oil. The offerings will also include both lotions and salves. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. CBD Global will expand the product offerings over the next two quarters in 2021 including CBD infused confectionary products and a hydration line featuring multi flavored energy drinks.
Learn more about Dog and Dog Unleashed CBD here.
The Aethics brand was born from the need for a trusted source for CBD (cannabidiol) sports wellness products. CBD Global’s founders saw a leadership void in this fast growing sports category, and a unique opportunity to create a brand that concentrates on individuals living active lifestyles.
Consumers are requesting natural, non-addicting solutions for pain relief, inflammation, insomnia, anxiety, nausea and related common and chronic ailments. The Aethics brand presents an informative, ethical destination for the athlete that is looking for safe alternatives in caring for their body and mind.
Aethics boasts 3 topical CBD creams, 5 CBD infused drinks and 3 CBD performance drops.
@TeamAethics | www.aethics.com
The CannaOil brand was created in 2016 to provide the highest quality CBD derived from hemp products on the market.
The hemp oil is obtained using a super cold extraction process on local Colorado plants, maximizing productions and quality. All hemp used to create the products is grown locally at Strasburg Pharms, which is pesticide free and only uses natural additives to craft the most effective product on the market.
Strasburg Pharms Certified is a stamp of CBD Hemp quality placed on the company’s products, and awarded to worthy third party companies throughout the US looking to develop their own brands and white labeled CBD products.
Certification ensures the following:
So what is hemp and CBD, and where’s the market for it? While there are many common misconceptions about the nature of hemp and CBD, you’d have to be living under a rock to think that there isn’t a huge market for these products.
Hemp is a part of cannabis, a type of flower in the Cannabaceae family, but it is not used to get you high like one hearing “cannabis” might think. THC (tetrahydrocannabinol) is a cannabinoid, or chemical, found in cannabis and is responsible for the “high” effects associated with the cannabis plant. To be legally labeled as hemp, there must be .3% or less THC in the product.
Most industrial hemp doesn’t produce many buds, and almost all the THC in the cannabis plant is formed in resin glands on the buds and flowers. Since industrial hemp isn’t grown to cultivate said buds, it lacks the main components that would get someone high. Industrial hemp also has higher concentrations of cannabidiol (CBD) which actually lessens the psychoactive effects of THC.
While the health benefits of the CBD continue to be explored, the World Health Organization has stated that CBD presents no evidence of abuse or dependence potential. The CBD retail industry is already booming, with a plethora of products marketed as treatments for chronic pain, anxiety, depression, and more. However, it seems the market is on the cusp of another swell.
Leading cannabis researchers BDS Analytics and Arcview Market Research projects that the collective market for CBD sales in the U.S. will exceed $20 billion by 2024. This is a slight increase from the recent estimation of $15 billion by 2025 by New York-based investment bank Cowen & Co.
BDS analytics also predicted a CBD growth rate of 49% across all distribution channels by 2024. There’s already a significant market for CBD products and it’s only going to get larger. As it continues to expand, so does the need for the most pure, full spectrum CBD possible, which CBD Global is in the perfect position to capitalize on.
Strasburg Pharms is a wholly owned subsidiary of CBD Global and controls approximately 179 contiguous acres of farmable land through lease and purchase. The company also has the opportunity to purchase up to an additional 3,485 acres contiguous to its current 179 acres in Strasburg, Colorado.
The leaders behind Strasburg Pharms want to bring organically grown and genetically beneficial hemp to market in the most economical way possible. With more than 60 years of agricultural experience on their team, they aim to provide the highest quality hemp in their sector.
Industrial hemp can be genetically bred to produce high CBD potency and low THC potency. To be clear, CBD is a non-psychoactive cannabinoid, so it can be used without gaining the feelings of lethargy and/or dysphoria. CBD doesn’t make you “high,” but it does offer many healing and calming benefits that consumers rely on.
All the farms cannabidiol comes from organically grown, lab extracted and tested, industrial hemp.Their plants are hand picked to produce full spectrum CBD with maximum potency and less than or equal to .3% THC. They never use chemicals or pesticides in their completely all-natural approach, regulated by the Department of Agriculture.
Strasburg Pharms also uses a cold fusion extraction process, where the terpenes and cannabinoids are sealed with super cold temperatures. It’s one of the most natural and effective ways to extract the pure oils from the plant matter. All of this combined means that Strasburg Pharms can produce massive and growing quantities of high potency and quality CBD.
Chief Executive Officer and President
Mr. Wyatt is the cofounder/CEO of CBD Global as well as Strasburg Pharms, SMBT, and CannaOil, which are all wholly owned subsidiaries of CBD Global.
Professional Background includes executive positions with Federal Mogul, Sears Roebuck, and the Target Corporation.
Founder of MAC5 Mortgage Inc. which operates in 6 states and employs over 100 people.
Scott Darnell is the Marketing Manager for CBD Global.
He is responsible for linking the innovations of the company’s product team to the customer-focused operations of the business, thus building the company’s global brand, creating consumer awareness and advocacy, and driving customer preference.
Chief Operating Officer
Mr. Dooley co-founded MAC5 Mortgage Inc. with Brad Wyatt in 2006.
Mr. Dooley holds a bachelor’s degree in Biology and brings to the team a breadth of knowledge and experience in management and startups.
Mr. Wyatt is currently the Supply Chain and Logistics Consultant with CBD Global.
Prior to this role, Jake was an expert in the supply chain area with various firms including Gencoa, FEDEX, and Sears Roebuck.
Mr. Wyatt holds a M.S in Transportation Management from Florida Institute of Technology and a degree in business administration from University of Tennessee.
Chief Financial Officer
Alexander McAulay CPA, CA is an experienced public company CFO.
Alex founded the successful Naked Brand Group Inc. (NASDAQ:NAKD) and led the company as its COO and CFO.
Alex is currently the CFO of Marifil Mines Limited (TSX-V:MFM), GreenStar Biosciences Corp. (CSE:GSTAR) and is the owner of a licensed accounting practice, ACM Management Inc., providing CFO advisory services to public companies.